AU474378B2 - Method and composition for dispensing unstable drugs - Google Patents

Method and composition for dispensing unstable drugs

Info

Publication number
AU474378B2
AU474378B2 AU47778/72A AU4777872A AU474378B2 AU 474378 B2 AU474378 B2 AU 474378B2 AU 47778/72 A AU47778/72 A AU 47778/72A AU 4777872 A AU4777872 A AU 4777872A AU 474378 B2 AU474378 B2 AU 474378B2
Authority
AU
Australia
Prior art keywords
dispensing
composition
unstable drugs
drugs
unstable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU47778/72A
Other versions
AU4777872A (en
Inventor
GEMMER STEHLE and THOMAS OVID OESTERLING RANDALL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of AU4777872A publication Critical patent/AU4777872A/en
Application granted granted Critical
Publication of AU474378B2 publication Critical patent/AU474378B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU47778/72A 1971-11-01 1972-10-16 Method and composition for dispensing unstable drugs Expired AU474378B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19468671A 1971-11-01 1971-11-01
USUS194686 1971-11-01

Publications (2)

Publication Number Publication Date
AU4777872A AU4777872A (en) 1974-04-26
AU474378B2 true AU474378B2 (en) 1976-07-22

Family

ID=22718538

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47778/72A Expired AU474378B2 (en) 1971-11-01 1972-10-16 Method and composition for dispensing unstable drugs

Country Status (9)

Country Link
AU (1) AU474378B2 (en)
BE (1) BE790840A (en)
DE (1) DE2251713A1 (en)
FR (1) FR2158405B1 (en)
GB (1) GB1367550A (en)
IL (1) IL40517A (en)
NL (1) NL7214204A (en)
PH (1) PH9756A (en)
ZA (1) ZA727077B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2740953A1 (en) * 1977-09-12 1979-03-22 Thera Ges Fuer Patente USE OF PROSTAGLANDINES TO LOWER BLOOD SUGAR LEVELS
US6693135B2 (en) 2000-01-10 2004-02-17 Nexmed (Holdings) Incorporated Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6323241B1 (en) 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US7105571B2 (en) 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
EP2408444A4 (en) * 2009-03-19 2012-09-26 Fate Therapeutics Inc Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same

Also Published As

Publication number Publication date
IL40517A (en) 1975-03-13
DE2251713A1 (en) 1973-05-10
FR2158405A1 (en) 1973-06-15
ZA727077B (en) 1973-06-27
BE790840A (en) 1973-04-30
IL40517A0 (en) 1972-12-29
AU4777872A (en) 1974-04-26
FR2158405B1 (en) 1976-07-02
PH9756A (en) 1976-03-12
NL7214204A (en) 1973-05-03
GB1367550A (en) 1974-09-18

Similar Documents

Publication Publication Date Title
CA983854A (en) Pharmaceutical composition containing nitroglycerin
AU432146B2 (en) Dispenser for flowable substances
CA956659A (en) Dispensing method and apparatus
CA968266A (en) Packaging mechanism and method
AU471970B2 (en) Container forliquid pharmaceutical composition
CA1003631A (en) Antiozonant-antioxidant composition and process for preparation thereof
AU474378B2 (en) Method and composition for dispensing unstable drugs
CA974554A (en) Jaw-operated cup dispensing mechanism and method
CA996026A (en) Hormone and process for the preparation thereof
CA944692A (en) Pharmaceutical composition and process for the preparation thereof
AU464055B2 (en) Dispensing apparatus and method
CA982525A (en) Tiltable aerosol dispensing
CA953217A (en) Pharmaceutical composition containing saccharides oligofructosans, polyfructosans and kestoses
CA963438A (en) Dispenser for flowable substances
AU461136B2 (en) Pharmaceutical composition
AU474389B2 (en) Method and composition for dispensing unstable drugs
CA880873A (en) Pharmaceutical composition and method
CA1000283A (en) Amino-indazole compounds, processes for making them and pharmaceutical compositions containing them
CA851164A (en) Pharmaceutical composition and method
CA857851A (en) Pharmaceutical composition and method
CA862580A (en) Medication dispensing means
CA941339A (en) Medication dispensing
CA884857A (en) Pharmaceutical composition
CA885421A (en) Pharmaceutical composition
CA874950A (en) Method for the administration of medicaments and articles therefor